Juvenescence is a clinical-stage biotech company developing therapies that target core aging mechanisms to prevent age-related diseases and extend healthy lifespan. By utilizing small molecules, biologics, and cell therapies, the company aims to transform aging into a healthier experience, reducing the burden of chronic diseases.
Funding
$231.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
As people age, they become more susceptible to age-related diseases, leading to a decline in healthspan and quality of life. Current treatments often focus on managing individual diseases rather than addressing the underlying mechanisms of aging.
Solution
Juvenescence is a clinical-stage biopharmaceutical company focused on developing therapeutics that target the core mechanisms of aging to prevent age-related diseases and extend healthy lifespan. The company utilizes a multi-modal approach, developing small molecules, biologics, and cell therapies designed to intervene in the aging process at a fundamental level. By focusing on early disease intervention and prevention, Juvenescence aims to transform aging into a healthier experience, reducing the burden of chronic diseases and improving overall well-being. Their pipeline includes multiple clinical medicines targeting aging mechanisms, with the goal of achieving disease modification and potentially increasing lifespan.
Target Audience
The primary target audience includes individuals at risk of or affected by age-related diseases, as well as healthcare providers and researchers focused on longevity and preventative medicine.
Features
- Development of therapies targeting core aging mechanisms
- Utilizes small molecules, biologics, and cell therapies
- AI-enabled R&D to design novel compounds and increase drug success rates
- Adaptive clinical trials using patient stratification, biomarkers, and AI-enabled real-time analysis
- Focus on early disease intervention and prevention